Şule Ketenci Ertaş

Publication Activity (10 Years)

Years Active: 2019-2019
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Ragıp Ertaş, Tomasz Hawro, Sabine Altrichter, Kemal Özyurt, Kemal Erol, Şule Ketenci Ertaş, Marcus Maurer
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU. Allergy 75 (2) (2019)